- Filed
- May 8, 2014 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2014 · May 8, 2014 | 125.98M sh |
| Shares Diluted | Q3 2014 · Mar 31, 2014 | 125.93M sh |
| Shares Diluted | Q3 2014 · Mar 31, 2014 | 125.35M sh |
| Shares Diluted | Q3 2014 · Mar 31, 2013 | 124.6M sh |
| Shares Diluted | Q3 2014 · Mar 31, 2013 | 124.55M sh |
| Capex | Q3 2014 · Mar 31, 2014 | $52.77M |
| Capex | Q3 2014 · Mar 31, 2013 | $64.59M |
| Operating Cash Flow | Q3 2014 · Mar 31, 2014 | $172.18M |
| Operating Cash Flow | Q3 2014 · Mar 31, 2013 | $286.2M |
| Long Term Debt | Q3 2014 · Mar 31, 2014 | $1.27B |
| Long Term Debt | Q3 2014 · Jun 30, 2013 | $1.27B |
| Long Term Debt | Q3 2014 · Mar 31, 2013 | $1.28B |
| Short Term Debt | Q3 2014 · Mar 31, 2014 | $11.88M |
| Short Term Debt | Q3 2014 · Jun 30, 2013 | $12.08M |
| Short Term Debt | Q3 2014 · Mar 31, 2013 | $12.08M |
| Cash And Equivalents | Q3 2014 · Mar 31, 2014 | $177.47M |
| Cash And Equivalents | Q3 2014 · Jun 30, 2013 | $130.7M |
| Cash And Equivalents | Q3 2014 · Mar 31, 2013 | $183.61M |
| Cash And Equivalents | Q3 2014 · Jun 30, 2012 | $191.01M |
| Stockholders Equity | Q3 2014 · Mar 31, 2014 | −$100.97M |
| Stockholders Equity | Q3 2014 · Jun 30, 2013 | $355.86M |
| Stockholders Equity restated | Q3 2014 · Mar 31, 2013 | $351M |
| Stockholders Equity restated | Q3 2014 · Jun 30, 2012 | $578.74M |
| Current Liabilities | Q3 2014 · Mar 31, 2014 | $454.02M |
| Current Liabilities | Q3 2014 · Jun 30, 2013 | $486.1M |
| Current Liabilities | Q3 2014 · Mar 31, 2013 | $486.4M |
| Current Assets | Q3 2014 · Mar 31, 2014 | $812.52M |
| Current Assets | Q3 2014 · Jun 30, 2013 | $771.62M |
| Current Assets | Q3 2014 · Mar 31, 2013 | $779.56M |
| Total Assets | Q3 2014 · Mar 31, 2014 | $1.88B |
| Total Assets | Q3 2014 · Jun 30, 2013 | $2.42B |
| Total Assets restated | Q3 2014 · Mar 31, 2013 | $2.46B |
| Eps Diluted | Q3 2014 · Mar 31, 2014 | −$3.71 |
| Eps Diluted | Q3 2014 · Mar 31, 2014 | −$3.80 |
| Eps Diluted restated | Q3 2014 · Mar 31, 2013 | −$2.09 |
| Eps Diluted restated | Q3 2014 · Mar 31, 2013 | −$1.95 |
| Eps Basic | Q3 2014 · Mar 31, 2014 | −$3.71 |
| Eps Basic | Q3 2014 · Mar 31, 2014 | −$3.80 |
| Eps Basic restated | Q3 2014 · Mar 31, 2013 | −$2.09 |
| Eps Basic restated | Q3 2014 · Mar 31, 2013 | −$1.95 |
| Net Income | Q3 2014 · Mar 31, 2014 | −$467.65M |
| Net Income | Q3 2014 · Mar 31, 2014 | −$476.07M |
| Net Income | Q3 2014 · Jun 30, 2013 | −$244.39M |
| Net Income restated | Q3 2014 · Mar 31, 2013 | −$260.41M |
| Net Income restated | Q3 2014 · Mar 31, 2013 | −$242.36M |
| Operating Income | Q3 2014 · Mar 31, 2014 | −$468.85M |
| Operating Income | Q3 2014 · Mar 31, 2014 | −$427.7M |
| Operating Income | Q3 2014 · Mar 31, 2013 | −$218.42M |
| Operating Income | Q3 2014 · Mar 31, 2013 | −$124.71M |
| Cost Of Revenue | Q3 2014 · Mar 31, 2014 | $356.86M |
| Cost Of Revenue | Q3 2014 · Mar 31, 2014 | $1.06B |
| Cost Of Revenue | Q3 2014 · Mar 31, 2013 | $350.13M |
| Cost Of Revenue | Q3 2014 · Mar 31, 2013 | $1.09B |
| Revenue | Q3 2014 · Mar 31, 2014 | $595.2M |
| Revenue | Q3 2014 · Mar 31, 2014 | $1.77B |
| Revenue | Q3 2014 · Mar 31, 2013 | $638.9M |
| Revenue | Q3 2014 · Mar 31, 2013 | $1.9B |
| Stock Issued | Q3 2014 · Oct 31, 2009 | 23M sh |